BodyBio

BodyBio, founded in 1998 and headquartered in the United States, is a pioneering force in the Biotechnology, Health Care, and Pharmaceutical sectors. With the slogan "Discover health at the cellular level," the company is committed to enhancing health through scientifically backed supplements. This third-generation, family-owned business has honed its focus on delivering premium, targeted formulations that address core bodily systems such as the gut, brain, liver, and hormones.

With a network of over 35,000 practitioners worldwide, BodyBio has established itself as a trusted and innovative leader in the wellness space. Its mission centers around empowering individuals by fostering cellular health, thereby promoting balanced and energized lifestyles.

The company last secured a $675.00K Seed Round investment on 15 May 2018, showcasing its continued growth potential and resilience in a competitive market. Investors seeking opportunities in health and biotechnology will find BodyBio a compelling candidate, given its robust scientific foundation and market presence.